What tests should I get after a Ocular Melanoma diagnosis

Tests After an Ocular Melanoma Diagnosis

After being diagnosed with ocular melanoma (also called uveal melanoma), your eye care team will recommend several tests to fully characterize your tumor and plan treatment. Here's what you should expect:

Initial Diagnostic & Characterization Tests

According to the NCCN Guidelines for Uveal Melanoma, the following tests help your doctors understand your specific tumor:

Eye Imaging & Measurement Tests

• Comprehensive dilated eye exam - Your ophthalmologist will carefully examine the back of your eye after dilating your pupils. This is often the primary way melanomas are diagnosed and characterized.
• Color fundus photography - Photos of your eye's interior to document the tumor's appearance and features
• Ocular ultrasound (A-scan and B-scan) - Sound wave imaging to measure tumor size, thickness, and shape
• Optical Coherence Tomography (OCT) - Detailed cross-sectional imaging of the retina and tumor
• Fundus autofluorescence - Special imaging that shows how the tumor fluoresces under specific light wavelengths
• Fluorescein angiography - Dye-based imaging to evaluate blood flow patterns in and around the tumor
• MRI - May be used to check if the tumor has extended beyond the eye into surrounding tissues

Critical Measurements Your Doctor Will Document

Your care team must measure and record:

• Visual acuity (how well you can see)
• Tumor location, diameter, and thickness
• Distance from the tumor to the optic disc and fovea (critical vision areas)
• Whether the ciliary body is involved
• Presence of subretinal fluid or orange pigment

Biopsy & Genetic Testing

According to NCCN Guidelines, biopsy is usually NOT necessary for initial diagnosis, but may be considered in specific situations:

• When diagnosis is uncertain (for example, with amelanotic tumors that lack pigment)
• For prognostic information - If performed, molecular/chromosomal testing is preferred over cytology alone, as this helps predict how aggressive your tumor may be
• For clinical trial eligibility - Some trials require genetic information

Your doctor will discuss the risks and benefits of biopsy with you, as it does carry some risks to the eye.

Systemic (Whole-Body) Staging Tests

Since uveal melanoma can spread to other parts of the body (most commonly the liver), your oncology team may recommend:

• Liver imaging - Ultrasound, CT scan, or MRI to check for metastases (spread), since the liver is affected in about 90% of cases where melanoma spreads
• Chest imaging - CT scan to evaluate the lungs (the second most common site of spread)
• Blood tests - Baseline labs to assess liver and kidney function before treatment

Important context: According to NCCN Guidelines, less than 3% of patients have detectable metastatic disease at the time of diagnosis, so many patients won't need extensive staging. Your doctor will determine what's appropriate based on your tumor characteristics.

Follow-Up Monitoring Schedule

After treatment, your follow-up schedule depends on your treatment type:

For patients treated with brachytherapy (radioactive plaque):

• Exam within 6 weeks of treatment
• At 6 months after treatment
• Every 6 months for 5 years
• Every 12 months thereafter

For patients treated with external beam radiation or other therapies:

• More frequent follow-up initially (sometimes 3-5 exams in the first 6 months)
• Then every 3-4 months during the first 1-2 years
• Long-term follow-up every 4-12 months

Follow-up exams typically include:

• Dilated eye exam with indirect ophthalmoscopy
• Slit-lamp examination
• Tonometry (eye pressure measurement)
• Visual acuity and visual field testing
• Ultrasound imaging
• Color fundus photography
• Fluorescein angiography (as needed)

Important Notes About Your Fellow Eye

According to NCCN Guidelines, your other eye is NOT at increased risk for melanoma. In COMS (Collaborative Ocular Melanoma Study) trials, less than 1% of patients developed disease in the other eye during follow-up. Your other eye should receive routine eye care with standard eye protection (polycarbonate glasses).

Questions to Ask Your Eye Care Team

1. Which of these tests do you recommend for my specific tumor? (Not all patients need all tests)
2. Will I need a biopsy, and if so, why? What are the risks and benefits?
3. What is my tumor's stage and size classification?
4. Do you recommend genetic/molecular testing for prognostic information?
5. What is my follow-up schedule after treatment?
6. How often should I have imaging to check for spread to the liver or other organs?
7. Are there any clinical trials I might be eligible for?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.